MSC2156119J
EMR 200095-003
Phase 1 small_molecule completed
Quick answer
MSC2156119J for Solid Tumors is a Phase 1 program (small_molecule) at Merck KGaA, Darmstadt, Germany with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed